Stockreport

Elicio Therapeutics Announces Closing of Private Placement of $20.0 Million Convertible Note

Elicio Therapeutics, Inc.  (ELTX) 
PDF BOSTON, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio Therapeutics” or “Elicio”), a clinical-stage biotechnology company developin [Read more]